Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial - Takeaways - MDSpire

Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial

  • By

  • Huakang Li

  • Yuanzhen Mi

  • Ke Xu

  • Ming Fan

  • Jun Yin

  • Qiang Li

  • Ziliang Wu

  • Cuicui Gong

  • Yunjing Jia

  • Pengxuan Gu

  • Shanshan Wei

  • Zhonglin Zhang

  • Shuo Zhang

  • Yuanyuan Zheng

  • Bing Lin

  • Jinyi Lang

  • Biao Zhao

  • Meihua Chen

  • June 23, 2026

  • 0 min

Share

  • 1

    The study aims to evaluate the effectiveness of Jishi Shuanghua Granules in preventing acute radiation-induced esophagitis in NSCLC patients undergoing CCRT.

  • 2

    240 patients with stage III NSCLC will be enrolled and randomly assigned to receive either JSG or a placebo in a double-blind trial.

  • 3

    Primary endpoints include the incidence rates of ARIE and severe ARIE, while secondary endpoints assess pain, dysphagia, and quality of life.

  • 4

    The trial will also explore the mechanisms of JSG through multi-omics analyses, including inflammatory cytokines and gut microbiota.

  • 5

    Jishi Shuanghua Granules consist of 12 herbal constituents and have been used clinically for over ten years to treat CCRT-induced ARIE.

Original Source(s)

Related Content